SCHEMBL3357995

SCHEMBL3357995

CCOC(=O)N1CCc2c(sc(NC(=O)C=Cc3cccc(Cl)c3)c2C#N)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.54
MEN1 O00255 9/20 0.53
KMT2A Q03164 9/20 0.53
ALDH1A1 P00352 7/20 0.53
MAPT P10636 6/20 0.53
HSD17B10 Q99714 4/20 0.53
TP53 P04637 3/20 0.53
LMNA P02545 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
NPSR1 Q6W5P4 3/20 0.53
TSHR P16473 1/20 0.53
KDM4E B2RXH2 4/20 0.53
GAA P10253 3/20 0.53
POLB P06746 2/20 0.49
HPGD P15428 3/20 0.46
ALOX15 P16050 2/20 0.46
TGFBR1 P36897 1/20 0.46
PDE4D Q08499 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
ALOX12 P18054 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13166067 1.00 L3MBTL1 (0.54) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL3357091 0.92 L3MBTL1 (0.55) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13166074 0.92 L3MBTL1 (0.55) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL3355782 0.92 L3MBTL1 (0.55) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13166192 0.92 L3MBTL1 (0.55) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13166080 0.91 L3MBTL1 (0.54) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL3356495 0.91 L3MBTL1 (0.54) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13166081 0.90 L3MBTL1 (0.57) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL3352868 0.90 L3MBTL1 (0.57) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL3353182 0.90 L3MBTL1 (0.59) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7803945-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-09-28 US claimed
EP-1753512-B1 TETRAHYDROPYRIDOTHIOPHENES NYCOMED GMBH (DE) 2008-07-09 EP claimed
US-7723523-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-05-25 US disclosed
EP-1753512-B1 TETRAHYDROPYRIDOTHIOPHENES NYCOMED GMBH (DE) 2008-07-09 EP disclosed
US-20070244112-A1 Novel tetrahydropyridothiophenes ALTANA PHARMA AG (DE) 2007-10-18 US disclosed
EP-1753512-A2 TETRAHYDROPYRIDOTHIOPHENES Altana Pharma AG (DE) 2007-02-21 EP disclosed
WO-2005118071-A2 TETRAHYDROPYRIDOTHIOPHENES ALTANA PHARMA AG (DE) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244112-A1 Novel tetrahydropyridothiophenes BAX, BCL2, BAD L3MBTL1 2161/4885MEN1 4610/4885KMT2A 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.